Advertisement

Five myths about AIDS that have misdirected research and treatment

  • Robert S. Root-Bernstein
Chapter
  • 49 Downloads
Part of the Contemporary Issues in Genetics and Evolution book series (CIGE, volume 5)

Abstract

A number of widely repeated and factually incorrect myths have pervaded the AIDS research literature, misdirecting research and treatment. Five of the most outstanding are: 1) that all risk groups develop AIDS at the same rate following HIV infection; 2) that there are no true seroreversions following HIV infection; 3) that antibody is protective against HIV infection; 4) that the only way to treat AIDS effectively is through retroviral therapies; and 5) that since HIV is so highly correlated with AIDS incidence, it must be the sole necessary and sufficient cause of AIDS. A huge body of research, reviewed in this paper, demonstrates the falsity of these myths. 1) The average number of years between HIV infection and AIDS is greater than 20 years for mild hemophiliacs, 14 years for young severe hemophiliacs, 10 years for old severe hemophiliacs, 10 years for homosexual men, 6 years for transfusion patients of all ages, 2 years for transplant patients, and 6 months for perinatally infected infants. These differences can only be explained in terms of risk-group associated cofactors. 2) Seroreversions are common. Between 10 and 20 percent of HIV-seronegative people in high risk groups have T-cell immunity to HIV, and may have had one or more verified positive HIV antibody tests in the past. 3) Antibody, far from being protective against HIV, appears to be highly diagnostic of loss of immune regulation of HIV, and some evidence of antibody-enhancement of infection exists. 4) Non-retroviral treatments of HIV infection, including safer sex practices, elimination of drug use, high nutrient diets, and limited reexposure to HIV and its cofactors have proven to be effective means of preventing or delaying onset of AIDS. 5) Many immunosuppressive factors, including drug use, multiple concurrent infections, and exposure to alloantigens, are as highly correlated with AIDS risk groups as HIV. These data are more consistent with AIDS being a multifactorial or synergistic disease than a monofactorial one.

Key words

AIDS progression HIV seroreversion HIV vaccination behavioural risks etiology 

References

  1. Adams, L.E., R. Donovan-Brand, A. Friedman-Kien, K. Ramahi & E.V. Hess, 1988. Sperm and seminal plasma antibodies in acquired immune deficiency (AIDS) and other associated syndromes. Clin. Immuno. Immunopathol. 46: 442–449.Google Scholar
  2. Anderson, R., 1993. AIDS: trends, predictions, controversy. Nature 363: 393–394.PubMedGoogle Scholar
  3. Andes, W.A., S.R. Rangan & K.M. Wulff, 1989. Exposure of heterosexuals to human immunodeficiency virus and viremia: evidence for continuing risks in spouses of hemophiliacs. Sex Transm. Dis. 16: 68–73.PubMedGoogle Scholar
  4. Anonymous, 1994. Fighting HIV: A clue from hemophilia. Science 263: 27.Google Scholar
  5. Ads, A., J.L. Pomar & E. Saura, 1993. Cardiopulmonary bypass in HIV-positive patients. Ann. Thorac. Surg. 55: 1104–1107.Google Scholar
  6. Aronson, D.L., 1988. Cause of death in hemophilia patients in the United States from 1968–1979. Am. J. Haematol. 27: 7–12.Google Scholar
  7. Atkinson, K., A.J. Dodds, A.J. Concannon & J.C. Biggs, 1987. The development of the acquired immunodeficiency syndrome after bone marrow transplantation. Med. J. Aust. 147: 510–512.PubMedGoogle Scholar
  8. Barnes, D.M., 1988. Obstacles to an AIDS vaccine. Science 240: 719–721.PubMedGoogle Scholar
  9. Biggar, R.J., H.K. Anderson, P. Ebbesen, M. Mebye & J.J. Goedert, 1983. Seminal fluid excretion of cytomegalovirus related to immunosuppression in homosexual men. Br. Med. J. 286: 2010–2012.Google Scholar
  10. Bjork, R.L. Jr., 1991. HIV-1: seven facets of functional molecular mimicry. Immunology Lett. 28: 91–95.Google Scholar
  11. Blanch, S., M. Tardieu, A. Duliege, C. Rouzioux, E le Deist, et al., 1990. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. Am. J. Dis. Child. 144: 1210–1215.Google Scholar
  12. Brown, P., 1992. AIDS researchers focus on immune response. New Scientist 8 August, 16.Google Scholar
  13. Buimovici-Klein, E., M. Lange, K.R. Ong, M.H. Grieco & L.Z. Cooper, 1988. Virus isolation and immune studies in a cohort of homosexual men. J. Med. Virol. 25: 371–385.PubMedGoogle Scholar
  14. Burke, D.S., 1992. Human HIV vaccine trials: Does antibody-dependent enchancement pose a genuine risk? Perspectives Biol. Med. 35: 511–531.Google Scholar
  15. Burger, H. & B. Weiser, 1986. Transient antibody to human immunodeficiency virus. Ann. Intern. Med. 105: 464–465.Google Scholar
  16. Burger, H., B. Weiser, W.S. Robinson, J. Lifson, E. Engleman, et al., 1985. Transient antibody to lymphadenopathy-associated virus/human T-lymphotopic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the aquired immonodeficiency syndrome. Ann. Int. Med. 103: 545–547.PubMedGoogle Scholar
  17. Callen, M., 1990. Surviving AIDS. New York: Harper Collins.Google Scholar
  18. Centers for Disease Control, 1993. HIV/AIDS Surveillance Report, June 1993.Google Scholar
  19. Clerici, M., J.V. Giorg i, C.C. Chou, V.K. Gudeman, J.A. Zack, P. Gupta, H.N. Ho, P.G. Nishanian, J.A. Berzofsky & G.M. Shearer, 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165: 1012–1019.PubMedGoogle Scholar
  20. Clerici, M. & G.M. Shearer, 1993. A TH1 -+ TH2 switch is a critical step in the etiology of HIV infection. Immunology Today 14: 107–111.PubMedGoogle Scholar
  21. Cohen, J., 1993. AIDS research: the mood is uncertain. Science 260: 1254–1255.PubMedGoogle Scholar
  22. Cooper, M.H., D. Maraninchi, J.A. Gastaut, P. Mannoni & Y. Carcassonne, 1993. HIV infection in autologous and allogeneic bone marrow transplant patients: a retrospective analysis of the Marseille bone marrow transplant population. J. Acquir. Immune. Defici. Syndr. 6: 277–284.Google Scholar
  23. Cuthbert, R.J.G., C.A. Ludlum, J. Tucker, et al.,1990. Five year prospective study of HIV infection in the Edinburgh haemophiliac cohort. Br. Med. J. 301: 956–961.Google Scholar
  24. Dalgleish, A.G., S. Wilson, M. Gompels, C. Ludlam, B. Gazzard, A.M. Coates & J. Habeshaw, 1992. T-cell receptor variable gene products and early HIV-1 infection. Lancet 339: 824–828.PubMedGoogle Scholar
  25. Daniel, V., R. Weimer, K. Schimpf & G. Opelz, 1989. Autoantibodies against CD4- and CD8-positive T lymphocytes in HIV-infected hemophilia patients. Vox Sang. 57: 172–176.PubMedGoogle Scholar
  26. Daniel, V., R. Weimer, R. Zimmerman, A. Huth-Kuhne, et al., 1991. Improving CD4+ lymphocyte counts in HIV-infected hemophilia patients: a favourable prognostic indicator? Immuno. Lett. 30: 27–30.Google Scholar
  27. Darby, S.C., R. Doll, B. Thakrar, C.R. Rizza & D.R. Cox, 1990. Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK. Stat. Med. 9: 681–689.PubMedGoogle Scholar
  28. De Biasi, R., A. Rocino, E. Miraglia, L. Mstrulle & A.A. Quirino, 1991. The impact of very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized prospective, two-year comparison with an intermediate purity concentrate. Blood 78: 1919–1922.PubMedGoogle Scholar
  29. Donohoe, R.M. & A.A. Falek, 1988. Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS. In: T.P. Bridge (ed.) Psychological, Neuropsychiatrie, and Substance Abuse Aspects of AIDS. New York: Raven Press, 165–172.Google Scholar
  30. Downs, A.M., R.A. Ancelle-Park, D. Costagliola, J.P. Rigaut & J.B. Brunet, 1991. Transfusion-associated AIDS cases in Europe: Estimation of the incubation period, distribution and prediction of future cases. J. Acquir. Immune. Defic. Syndr. 4: 805–813.PubMedGoogle Scholar
  31. Dudding, B.A., S.C. Wagner, J.A. Zeller, J.T. Gmelich, G.R. French & F.H. Top, Jr., 1972. Fatal pneumonia associated with adenovirus type 7 in three military trainees. New Engl. J. Med. 286: 1289–1292.PubMedGoogle Scholar
  32. Duesberg, P.H., 1987. Retroviruses as carcinogens and pathogens. Expectations and reality. Cancer Res. 47: 1199–1226.PubMedGoogle Scholar
  33. Duesberg, P.H., 1989. Human immunodeficiency virus and acquired immunodeficiency syndrome: Correlation but not causation. Proc. Natl. Acad. Sci. U.S.A. 86: 755–764.PubMedGoogle Scholar
  34. Duesberg, P.H., 1990. AIDS: non-infectious deficiencies acquired by drug consumption and other risk factors. Res. Immunol. 141: 5–17.PubMedGoogle Scholar
  35. Duesberg, P.H., 1992. The role of drugs in the origin of AIDS. Biomed. & Pharmacother. 46: 3–15.Google Scholar
  36. Drew, W.L., J. Mills, J. Levy, etal.,1985. Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. Ann. Intern. Med. 103: 61–63.PubMedGoogle Scholar
  37. European Study Group on AIDS, 1989. Risk factors for male to female transmission of HIV. Br. Med. J. 298: 411–415.Google Scholar
  38. Eyster, M.E., M.H. Gail, J.O. Ballard, H. Al-Mondhiry & J.J. Goedert, 1987. Natural history of human immunodeficiency virus infections in hemophiliacs: effects on T-cell subsets, platelet counts and age. Ann. Intern. Med. 107: 1–6.PubMedGoogle Scholar
  39. Farrugia, A., 1992. Purity of factor concentrates and immune function in hemophiliacs. Blood 78: 1919–1922.Google Scholar
  40. Fauci, A.S., 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262: 1011–1018.PubMedGoogle Scholar
  41. Farzadegan, H., M.A. Polis, S.M. Wolinsky, C.R. Rinaldo Jr., J.J. Sninsky, S. Kwok, R.L. Griffiths, R.A. Kaslow, J.P. Phair, B.F. Polk & A.A. Saah, 1988. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. Ann. Med. 108: 785–790.Google Scholar
  42. Fernandez-Cruz, E., A.M. Fernandez, C. Gutierrez, et al., 1988. Progressive cellular immune impairment leading to development of AIDS: Two year prospective study of HIV infection in drug addicts. Clin. Exp. Immunol. 72: 190–195.Google Scholar
  43. Fiala, M., L.A. Cone, C.-M. Chang & E.S. Mocarski, 1986. Cytomegalovirus viremia increases with progressive immune deficiency in patients infected with HTLV-III. AIDS Res. 2: 175–181.PubMedGoogle Scholar
  44. Fribourg-Blanc, A., 1988. Deux observations d’annulation spontanee d’une sero-positivite HIV. Med. Mal. Infect. 4: 216–218.Google Scholar
  45. Fumento, M., 1990. The Myth of Heterosexual AIDS, New York, Harpers.Google Scholar
  46. Garry, R.F., J.J. Kort, F. Koch-Nolte & G. Koch, 1991. Tat contains a sequence related to snake neurotoxins. AIDS. 5: 1381–1384.PubMedGoogle Scholar
  47. Gibbons, J., J.M. Cory, I.K. Hewlett, J.S. Epstein & M.E. Eyster, 1990. Silent infections with human immunodeficiency virus type 1 are highly unlikely in multitransfused seronegative hemophiliacs. Blood 76: 1924–1926.PubMedGoogle Scholar
  48. Giesecke, J., G.P. Scalia-Tomba, O. Berglund, E. Berntorp, S. Schulman & L. Stigendal, 1988. Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. Br. Med. J. 297: 99–102.Google Scholar
  49. Goedert, J.J., C.M. Kessler, L.M. Aledort, et al., 1989. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. New Engl. J. Med. 321: 1141–1148.Google Scholar
  50. Golding. H., F.A. Robey, F.T. Gates III, W. Linder, et al., 1988. Indentification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. J. Exp. Med. 167,914–923.PubMedGoogle Scholar
  51. Goldsmith, J.M., J. Deutsche, M. Tang & D. Green, 1991. CD4 cells in HIV-1 infected hemophiliacs: effect of Factor VIII concentrates. Thromb. Haemost. 66: 415–419.Google Scholar
  52. Gottlieb, M.S., R.A. Zackin, M. Fiala, D.H. Henry, A.J. Marcel., K.L. Combs, J. Vieira, et al.,1991. Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. Ann. Intern. Med. 115: 84–91.PubMedGoogle Scholar
  53. Gomperts, E.D., R. De Biasi & R. De Vreker, 1992. The impact of clotting factor concentrates on the immune system in individuals with hemophilia. Transfus. Med. Rev. 6: 44–54.PubMedGoogle Scholar
  54. Gougeon, M.-L. & L. Montagnier, 1993. Apoptosis and AIDS. Science 260: 1296–1271.Google Scholar
  55. Groenbladh, L. & L. Gunne, 1989. Methadone-assisted rehabilitation of Swedish heroin addicts. Drug Alcohol Depend. 24:31–37.Google Scholar
  56. Gürtler, L., J. Eberle & E Deinhardt, 1989. Seroreversion in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 110: 946–948.PubMedGoogle Scholar
  57. Hadden, J.W., 1991. Immunotherapy of human immunodeficiency virus infection. Trends Pharmcol. Sci. 12: 107–111.Google Scholar
  58. Halstead, S.B., 1988. Pathogenesis of dengue: Challenges to molecular biology. Science 29: 476–481.Google Scholar
  59. Hamilton, J.R., J.C. Overall & L.A. Glasgow, 1976. Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aerugionsa, Staphylococcus aureus, or Candida albicans infections. Infect. Immunol. 14: 928–989.Google Scholar
  60. Hardy, A.M., J.R. Allen, W.M. Morgan & J.W. Curran, 1985. The incidence rate of acquired immune deficiency syndrome in selected populations. JAMA 253: 215–218.PubMedGoogle Scholar
  61. Hassett, J., G.F. Gjerset, J.W. Mosley, M.A. Fletcher, et al., 1993. Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-l-negative congenital clotting disorders. Blood 82: 1351–1357.PubMedGoogle Scholar
  62. Haverkos, H.W., 1988. Kaposi’s sarcoma and nitrite inhalants. In: T.P. Bridge (ed.) Psychological, Neuropsychiatrie, and Substance Abuse Aspects of AIDS. New York: Raven Press, 165–172.Google Scholar
  63. Hay, C.R., P. McEvoy & M. Duggan-Keen, 1990. Inhibitions of lymphocyte IL2-receptor expression by factor VIII concentrate: a possible cause of immune suppression in haemophiliacs. Br. J. Haematol. 75: 278–281.PubMedGoogle Scholar
  64. Hendricks, I.C., G.F. Medley, G.J. Van Griensven, R.A. Coutinho, et al., 1993. The treatment-free incubation period of AIDS in a cohort of homosexual men. AIDS 7: 231–239.Google Scholar
  65. Henrard, D.R.Y. Laurian, W.F. Mehaffey & J.P Allain, 1993. Lack of detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction in the plasma and lymphocytes of seronegative exposed hemophiliacs. Transfusion 33: 405–408.PubMedGoogle Scholar
  66. Higgins, J.A. & A.H. Goodall, 1991. Immune activation in HIVseronegative hemophiliacs: Is this related to infection with hepatitis C virus? Thromb. Haemost. 65: 1163 (abstr. 1682).Google Scholar
  67. Hilgartner, M.W., J.D. Buckley, E.A. Operskalsi, M.C. Pike & J.W. Mosely, 1993. Purity of factor VIII concentrates and serial CD4 counts. Lancet 341: 1373–1374.PubMedGoogle Scholar
  68. Hoff, C. & R.D.A. Peterson, 1989. Does exposure to HLA alloantigens trigger immunoregulatory mechanisms operative in both pregnancy and AIDS? Life Sci. 45: iii-ix.Google Scholar
  69. Hoff, C., W.C. James, R.B. Hester, P. Nolan & R.D.A. Peterson, 1991. Signs of cellular immunosuppression correlate with HLADR phenotypes in healthy HIV-negative homosexuals: preliminary findings. Human Biology 63: 129–135.PubMedGoogle Scholar
  70. Holman, R.C., P.H. Rodes, T.L. Chorba & B.L. Evatt, 1992. Survival of hemophiliac males with acquired immunodeficiency syndrome with and without risk factors for AIDS other than hemophilia. Am. J. Hematol. 39: 275–282.PubMedGoogle Scholar
  71. Hoover, D.R., A.J. Saah, H. Bacellar, et al., 1993. Clinical manifestation of AIDS in the era of pneumocystis prophylaxis. New Engl. J. Med. 329: 1922–1926.PubMedGoogle Scholar
  72. Horsburgh, C.R., Jr., C.Y. Ou, J. Jason, et al., 1990. Concordance of polymerase chain reaction with human immunodeficiency virus antibody detection. J. Infect. Dis. 162: 542–545.PubMedGoogle Scholar
  73. Huang, S.-W. & R. Hong, 1973. Lymphopenia and multiple viral infections. JAMA 225: 1120–1121.PubMedGoogle Scholar
  74. Huang, S.-W., D.B. Lattos, D.B. Nelson, K. Reb & R. Hong, 1973. Antibody-associated lymphotoxin in acute infection. J. Clin. Invest. 52: 1033–1040.PubMedGoogle Scholar
  75. Hughes, M.D., D.S. Stein, H.M. Gundacker, F.T. Valentine, J.P. Phair & P.A. Volberding, 1994. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: Implications for patient monitoring. J. Infect Dis. 169: 28–36.PubMedGoogle Scholar
  76. Imagawa, D. & R. Detels, 1991. HIV-1 in seronegative homosexual men. NEJM 325: 1250–1251.PubMedGoogle Scholar
  77. Jaffe, H.W., P.M. Feorino, W.W. Darrow, et al., 1985. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men. Ann. Intern. Med. 102: 627.PubMedGoogle Scholar
  78. Judson, F.N., 1990. The relationship of HIV infections to infections with pathogenic Neisseria in homosexual men. Med. Clin. North. Am. 74: 1353–1366.PubMedGoogle Scholar
  79. Kallenius, G., S.E. Hoffner & S.B. Svenson, 1989. Does vaccination with bacille Calmette-Guerin protect against AIDS? Rev. Infect. Dis. 11: 349–351.PubMedGoogle Scholar
  80. Keay, S., C.O. Tacket, J.R. Murphy & B.S. Handwerger, 1992. Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp160 or HIV-1 or infected with HIV-1. AIDS Res. Human Retroviruses 8: 1091–1098.Google Scholar
  81. Kion, T.A. & G.W. Hoffmann, 1991. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice. Science 253: 1138–1140.PubMedGoogle Scholar
  82. Klenk, H.D. & R. Rott, 1988. The molecular biology of influenza virus pathogenicity. Adv. Virus Res. 34: 247–281.Google Scholar
  83. Kliks, S.C., A. Nisalak, W.E. Brandt, et al., 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40: 444–451.PubMedGoogle Scholar
  84. Knüver-Hopf, J., H. Heinze, B. Lambrecht, H. Mohr, J. Beyer & H. Schmitt, 1993. Blood donations indeterminate in HIV-1 Western blot analysed by 1gM immunoblot and polymerase chain reaction. Vox Sang. 64: 89–93.PubMedGoogle Scholar
  85. Kopec-Schrader, E., B. Tindall, J. Learmont, B. Wylie & J.M. Kaldor, 1993. Development of AIDS in people with transfusion-acquired HIV infection. AIDS 7: 1009–1013.PubMedGoogle Scholar
  86. Krasinski, K., W. Borkowsky & R.S. Holzman, 1989. Prognosis of human immunodeficiency virus infection in children and adolescents. Pediatr. Infect. Dis. J. 8: 216–220.PubMedGoogle Scholar
  87. Lafeuillade, A. & R. Quilichine, 1992. HIV cofactors in the course of AIDS. Presse Med. 21: 1426–1430.PubMedGoogle Scholar
  88. Lang, Ph., P. Niaudet, and the Groupe Cooperatif de Transplantation de l’Ile de France, 1991. Update and outcome of renal transplant patients with human immunodeficiency virus. Transplantation Proc. 23: 1352–1353.Google Scholar
  89. Laurence, J., 1993. T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia. Ann. Intern. Med. 119: 55–62.PubMedGoogle Scholar
  90. Levy, J., 1988. The transmission of AIDS: the case of the infected cell. JAMA 259: 3037–3038.PubMedGoogle Scholar
  91. Littlefield, J.W., 1992. Possible supplemental mechanisms in the pathogenesis of AIDS. Clin. Immunol. Immunopathol. 65: 85–97.Google Scholar
  92. Lo, S.-H., S. Tsai, J.R. Benish, et al., 1991. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma. Science 251: 1074–1076.PubMedGoogle Scholar
  93. Lorenzo, J.I., R. Molina & J.A. Aznar, 1993. Evolution of CD4 and CD8 lymphocyte subsets in HIV seronegative and seropositive hemophiliacs. Sangre Barc. 38: 5–11.PubMedGoogle Scholar
  94. Ludlum, C.A., J. Tucker, C.M. Steel, et al., 1985. Human Tlymphotropic virus type III (HTLV-III) infection in seronegative hemophiliacs after transfusions of factor VIII. Lancet 11: 233–236.Google Scholar
  95. Lui, K.-J., D.N. Lawrence, W.M. Morgan, T.A. Peterman, H.W. Haverkos & D.J. Bregman, 1986. A model based approach for estimating the mean incubation period of transfusion-associated acquired immunodeficiency syndrome. Proc. Natl. Acad. Sci. U.S.A. 83: 301–305.Google Scholar
  96. Lusso, P., R. Ensoli, P.D. Markham, et al., 1989. Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature (Lond.), 337: 370–373.Google Scholar
  97. Lusso, E, F. Lori & R.C. Gallo, 1990. CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses. J. Virol. 64: 6341–6344.PubMedGoogle Scholar
  98. Macon, W.R., S.-C. Lo, B.J. Poisz, D.C. Monefiori, et al., 1993. Acquired immunodeficiency-syndrome-like illness associated with systemic Mycoplasma fermentans infection in a human immunodeficiency virus-negative homosexual man. Human Pathol 24:Google Scholar
  99. Madhok, R., J.A. Gracie, J. Smith, G.D. Lowe & C.D. Forbes, 1990. Capacity to produce interleukin 2 is impaired in haemophilia in the absence and presence of HIV 1 infection. Br. J. Haematol. 76: 70–74.PubMedGoogle Scholar
  100. Madhok, R., J. Smith, A. Jenkins & G.D.O. Lowe, 1991. T-cell sensitization to factor VIII in haemophilia A? Br. J. Haematol. 79: 235–238.PubMedGoogle Scholar
  101. Mannucci, P.M., A. Gringeri, R. De Biasi, F. Baudo, M. Morfini & N. Ciavarella, 1992. Immune status of asymptomatic HIV-infected haemophiliacs: randomized, prospective, two-year comparison of treatment with high-purity or an intermediate-purity factor VIII (FVIII). Thromb. Haemost. 67: 310–313.Google Scholar
  102. Mares, M., M.T. Sartori & A. Girolami, 1992. Prevalence of bleeding as cause of death in HIV-seropositive patients with congenital clotting disorders. Vox Sang. 63: 77–78.PubMedGoogle Scholar
  103. Mathé, G., 1992. Is the AIDS virus responsible for the disease? Biomed. Pharmacother. 46: 1–2.PubMedGoogle Scholar
  104. McClean, A.R. & M.A. Nowak, 1992. Models of interactions between HIV and other pathogens. J. Theor. Biol. 155: 69–86.Google Scholar
  105. McDougal, J.S., M. Hubbard, J.K.A. Nicholson, et al., 1985. Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect. J. Clin. Immunol. 5: 130.PubMedGoogle Scholar
  106. Medawar, P.B., 1967. The art of the soluble. London: Methuen.Google Scholar
  107. Medley, G.F., R.M. Anderson, D.R. Cox & L. Billard, 1987. Incubation period of AIDS in patients infected via blood transfusion. Nature 328: 719–721.PubMedGoogle Scholar
  108. Mills, L.B., 1986. Stimulation of T-cellular immunity by cutaneous application of dinitrochlorobenzene. J. Am. Acad. Dermatol. 14: 1089–1090.PubMedGoogle Scholar
  109. Minkoff, H., D. Nanda, R. Menez & S. Fikrig, 1987. Pregnancies resulting in infants with acquired immunodeficiency syndrome or AIDS-related complex: follow-up of mothers, children, and subsequently born siblings. Obstet. Gynecol. 69: 288–291.Google Scholar
  110. Montagnier, L., D. Bernman, D. Guetard, A. Blanchard, et al., 1990. Inhibition de l’infectiosite de souches prototype du VIH par des anticorps diriges contre une sequence peptideque de mycoplasme. Comptes rendus Acad. Sci. Paris 311: 425–430.Google Scholar
  111. Montaner, J.S., L.M. Lawson, A. Gervais, et al.,1991. Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. A randomized, placebo-controlled study. Ann. Intern. Med. 114: 948–953.PubMedGoogle Scholar
  112. Moretti, M.L., 1992. Specific behavioural factors among intravenous drug users have been shown to influence HIV seroconversion… J. InterAm. Med. Health. Assoc. 1: 1–8.Google Scholar
  113. Morrow, W.J.W., D.A. Isenberg, R.E. Sobol, R.B. Stricker & T. Keiber-Emmons, 1991. AIDS virus infection and autoimmunity: A perspective on the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease. Clin. Immunol. Immunopathol. 58,163–180.Google Scholar
  114. Msellati, E, M. Dupon, P. Morlat, D. Lacoste, et al., 1990. A cohort study of 89 HIV-1-infected adult patients contaminated by blood products: Bordeaux 1981–1989. AIDS 4: 1105–1109.PubMedGoogle Scholar
  115. Munoz, A., V. Carey, A.J. Saah, et al., 1988. Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J. Acquir. Immune. Defic. Syn. 1: 396.Google Scholar
  116. National Research Council. 1990. AIDS: The Second Decade National Academy of Sciences, Washington, D.C.Google Scholar
  117. Naz, R.K., M. Ellauri, T.M. Phillips & J. Hall, 1990. Antisperm antibodies in human immunodeficiency virus infection: Effects on fertilization and embryonic development. Biol. Reprod. 42: 859–868.PubMedGoogle Scholar
  118. Odell, T.W. & J.A. Green, 1990. Prolonged zidovudine therapy: confounded by Pneumocysitis carinii prophylaxis? JAMA 263: 1635.PubMedGoogle Scholar
  119. Oehen, S., H. Hengartner & R.M. Zinkernagel, 1991. Vaccination for disease. Science 251: 195–198.PubMedGoogle Scholar
  120. Ozturk, G.E., P.F. Kohler, C.R. Horsburgh & C.H. Kirkpatrick, 1987. The significance of antilymphocyte antibodies in patients with acquired immune deficiency syndrome (AIDS) and their sexual partners. J. Clin. Immunol. 7: 130–133.PubMedGoogle Scholar
  121. Padian, N.S., S.C. Shiboski & N.P. Jewell, 1990. The effect of number of exposures on the risk of heterosexual HIV transmission. J. Infect. Dis. 161: 883–887.PubMedGoogle Scholar
  122. Palestine, A.G., M.A. Polis, M.D. De Smet, et al., 1991. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann. Intern. Med. 115:665–671.PubMedGoogle Scholar
  123. Papadopulos-Eleopulos, E., 1988. Reappraisal of AIDS. Is the oxidation induced by the risk factors the primary cause? Med. Hypotheses 25: 151–162.PubMedGoogle Scholar
  124. Perrin, L.H., R. Zubler, B. Hirschel, J.L. Martin, D. Salomon, J.H. Sauret & O. Fryc, 1988. Negativation d’une serologie positive pour le virus d’immunodefience humaine (VIII). A propos de deux observations. Schweiz. Med. Wochenschrt. 118/45: 1641–1644.Google Scholar
  125. Peterman, T.A., R.L. Stoneburner, J.R. Allen, H.W. Jaffe & J.W. Curran, 1988. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. JAMA 259: 55–58.PubMedGoogle Scholar
  126. Pifer, L.W., Y.F. Wang, T.M. Chiang, R. Ahokas, D.R. Woods & R.E. Joyner, 1987. Borderline immunodeficiency in male homosexuals: Is lifestyle contributory? South. Med. J. 80: 687–697.PubMedGoogle Scholar
  127. Popper, K., 1962. Conjectures and refutations. The growth of scientific knowledge. New York: Basic Books.Google Scholar
  128. Porterfield, J.S., 1986. Antibody-dependent enhancement of viral activity. Adv. Virus. Res. 31: 335–353.PubMedGoogle Scholar
  129. Rahman, M.A., L.A. Kingsley, M.K. Berinig, et al., 1989. Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus. J. Clin. Microbiol. 29: 1215–1220.Google Scholar
  130. Ribot, S. & H.H. Eslami, 1992. HIV infection in kidney transplant recipients. N. J. Med. 89: 597–599.PubMedGoogle Scholar
  131. Rinaldo, C.R. Jr., L.A. Kingsley, D.W. Lyter, et al., 1986. Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men. J. Infect. Dis. 154: 556–561.PubMedGoogle Scholar
  132. Rinaldo, C.R., Jr., L.A. Kingsley, M. Ho, J.A. Armstrong & S.Y.J. Zhou, 1992. Enhanced shedding of cytomegalovirus in semen of human immunodeficiency virus-seropositive homosexual men. J. Clin. Microbiol. 30: 1148–1155.PubMedGoogle Scholar
  133. Ritter, M., 1994. AIDS raises death rate for hemophilia. Associated Press release based on CDC press conference, 3 Feb. 1994.Google Scholar
  134. Roithmann, S., J.M. Tourani, J.A. Gastaut, P. Brice, et al., 1993. Hodgkin’s disease associated with HIV infection: clinical characteristics and development. Bull. Cancer. Paris. 79: 873–882.Google Scholar
  135. Root-Bernstein, R.S., 1989. Discovering, Inventing and solving problems at the frontiers of knowledge. Cambridge, MA: Harvard University Press.Google Scholar
  136. Root-Bernstein, R.S., 1990a. Do we know the cause(s) of AIDS? Persp. Biol. Med. 33: 480–500.Google Scholar
  137. Root-Bernstein, R.S., 1990b. Multiple-antigen-mediated autoimmunity (MAMA) in AIDS: a possible model for postinfectious autoimmune complications. Res. Immunol. 141: 321–339.Google Scholar
  138. Root-Bernstein, R.S., 1990c. Non-HIV immunosuppressive agents in AIDS: a multifactorial, synergistic theory of AIDS aetiology. Res. Immunol. 141: 815–838.Google Scholar
  139. Root-Bernstein, R.S., 1991. Self, nonself, and the paradoxes of autoimmunity. In: A.I. Tauber, ed. Organism and the Development of Self. Kluwer Academic, pp. 159–209.Google Scholar
  140. Root-Bernstein, R.S., 1992a. HIV and immunosuppressive cofactors in AIDS. EOS. Rev. Immunol. lmmunopharm. 12: 256–262.Google Scholar
  141. Root-Bernstein, R.S., 1992b. AIDS is more than HIV. Genetic Engineering News 12 no. 13: 4–6; 12 no. 14:4–5.Google Scholar
  142. Root-Bernstein, R.S., 1993. Rethinking AIDS. The Tragic Cost of Premature Concensus. New York: Free Press.Google Scholar
  143. Root-Bernstein, R.S., 1994. Preliminary evidence of idiotypeantiidiotype immune complexes cross-reactive with lymphocyte antigens resulting from pairs of infectious agents associated with AIDS and lupus. Med. Hypoth. In press.Google Scholar
  144. Root-Bernstein, R.S. & S.H. Hobbs. 1991. Homologies between mycoplasma adhesion pepetide, CD4, and class II MHC proteins: a possible mechanism for HIV-mycoplasma synergism in AIDS. Res. Immunol. 142: 519–523.PubMedGoogle Scholar
  145. Root-Bernstein, R.S. & S.H. Hobbs, 1993. Does HIV `piggyback’ on CD4-like surface proteins of sperm, viruses, and bacteria? Implications for co-transmission, cellular tropism and the induction of autoimmunity in AIDS. J. Theor. Biol. 160: 249–264.PubMedGoogle Scholar
  146. Root-Bernstein, R.S. & S.H. DeWitt, 1994. CD4 similarity to proteins of infectious agents in AIDS, and autoimmunity. Med. Hypoth. In press.Google Scholar
  147. Rosendaal, F.C., C. Smit & E. Briet, 1991. Hemophilia treatment in historical perspective: a review of medical and social developments. Ann. Hematol. 62: 5–25.PubMedGoogle Scholar
  148. Roy, M.J., J.J. Damato & D.S. Burke, 1993. Absence of true seroreversion of HIV-1 antibody in seroreactive individuals. JAMA 269: 2876–2879.PubMedGoogle Scholar
  149. Rubenstein, A., M. Sicklick, A. Gupta, L. Bernstein, N. Klein, et al.,1983. Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA 249: 2350–2356.Google Scholar
  150. Rubin, H., 1988. Etiology of AIDS. Science 214: 1389–1390.Google Scholar
  151. Sabin. A., 1988. Effectiveness of AIDS vaccines. Science 251: 1161.Google Scholar
  152. Sabin, C., A. Phillips, J. Elford, P. Griffiths, G. Janossay & C. Lee, 1993. Progression of HIV disease in a haemophiliac cohort followed for 12 years. Br. J. Haemoatol. 83: 330–335.Google Scholar
  153. Salk, J.P.A. Bretscher, P.L. Salk, M. Clerici & G.M. Shearer, 1993. A strategy for prophylactic vaccination against HIV. Science 260: 1270–1272.PubMedGoogle Scholar
  154. Schinaia, N., A. Ghirardini, F. Chiarotti, A. Gringeri, P.M. Mannucci, et al., 1991. Progression of AIDS among Italian HIVseropositive haemophiliacs. AIDS 5/4: 385–391.PubMedGoogle Scholar
  155. Schulman, S., 1991. Effects of factor VIII concentrates on the immune system of hemophiliac patients. Ann. Hematol. 63; 145–151.PubMedGoogle Scholar
  156. Schwarz, A., G. Offerman, F. Keller, I. Bennhold, J. L’age-Stehr, P.H. Krause & M.J. Mihatsch, 1993. The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation data on four cases and review of the literature. Transplantation 55: 95–103.PubMedGoogle Scholar
  157. Shearer, G.M. & R.B. Levy, 1984. Noninfectious cofactors in susceptibility to AIDS: possible contributions of semen, HLA alloantigens, and lack of natural resistance. Ann. N. Y. Acad. Sci. 437: 49–57.PubMedGoogle Scholar
  158. Shope, E., 1931. Swine influenza, III. Filtration experiments and etiology. J. Exp. Med. 54: 373–385.PubMedGoogle Scholar
  159. Sonnabend, J.A., 1989. AIDS: An explanation for its occurrence in homosexual men. In: AIDS and Opportunistic Infections of Homosexual Men, P. Ma and D. Armstrong, eds. Butterworth Publishers, Stoneham, MA, pp. 450–460.Google Scholar
  160. Sonnabend, J.A. & S. Saadoun, 1984. The acquired immunodeficiency syndrome: A discussion of etiologic hypothesis. AIDS Res. 1: 107–120.Google Scholar
  161. Sonnabend, J.A., S.S. Witkin & D.T. Portillo, 1984. A multifactorial model for the development of AIDS in homosexual men. Ann. N. Y. Acad. Sciences 437: 177–182.Google Scholar
  162. Sorice, F., A. Ghirardini, P. Martino, D. Pasqualetti, et al., 1989. Spectrum of HIV infection and AIDS in a cohort of Italian hemophiliacs. Haemotologica 74: 149–154.Google Scholar
  163. Stehr-Green, J.K., J.M. Jason, B.L. Evatt, R.C. Holman, et al., 1989. Geographic variability of hemophilia-associated AIDS in the United States: Effect of population characteristics. Am. J. Hematol. 32: 178–183.PubMedGoogle Scholar
  164. Stott, E.J., 1991. Anti-cell antibody in macaques. Nature 353: 393–395.PubMedGoogle Scholar
  165. Stricker, R.B., T.M. McHugh, D.J. Moody, W.J.M. Morrow, D.P. Stites, M.A. Shuman & J.A. Levy, 1987a. An AIDS-related cytotoxic antoantibody reacts with a specific antigen on stimulated CD4+ cells. Nature 327: 710–713.Google Scholar
  166. Stricker, R.B., T.M. McHugh, P.A. Marx, W.J.M. Morrow, J.A. Levy, M.A. Shuman, D.P. Stites & P.D. Nyeman, 1987b. Prevalence of an AIDS-related autoantibody against CD4+ T-cells in humans and monkeys. Blood 70: 127A.Google Scholar
  167. Stricker, R.B., B.F. Elswood & D.I. Abrams, 1991. Dendritic cells and dinitrochlorobenzene (DNCB): a new treatment approach to AIDS. Immunol. Lett. 29: 191–196.PubMedGoogle Scholar
  168. Stricker, R.B., B.F. Elswood, D.I. Abrams, et al., 1993. Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection. Immunol. Lett. 36: 1–6.PubMedGoogle Scholar
  169. Sullivan, J.L., F.E. Brewster, D.B. Brettler, et al., 1986. Hemophiliac immunodeficiency: Influence of exposure to factor VIII concentrate, LAV-HTLV-III, and herpes viruses. J. Pediatr. 108: 504–510.PubMedGoogle Scholar
  170. Sumaya, C.V., R.N. Boswell, Y. Ench, et al.,1985. Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS related complex. J. Infect Dis. 154: 864.Google Scholar
  171. Süsal, C., M. Kröpelin, V. Daniel & G. Opelz, 1993. Molecular mimicry between HIV-1 and antigen receptor molecules: a clue to the pathogenesis of AIDS. Vox Sang. 65: 10–17.PubMedGoogle Scholar
  172. Tanenbaum, S.A., R.F. Garry, H. Luo-Zhang, S.S. Alexander & C.A. Leissinger, 1993. Humoral and cellular responses against HIV in multitransfused HIV seronegative hemophiliacs. Absts. 1st National Conf. Human Retroviruses. Abst. #86, p. 71.Google Scholar
  173. Tanenbaum, S.A., C.A. Leissinger & R.P. Garry. 1993. Absence of seroconversion of HIV-1 antibody in seroreactive individuals. JAMA 270: 2178.Google Scholar
  174. Taylor, J.M., J.M. Duo & R. Detels, 1991. Is the incubation period of AIDS lengthening? J. Acquir. Immune. Defic. Syndr. 4: 69–75.PubMedGoogle Scholar
  175. Tzakis, A.G., M.H. Cooper, J.S. Dummer, M. Ragni, J.W. Ward & T.E. Starzl, 1990. Transplantation in HIV+ patients. Transplantation 49: 354–358.PubMedGoogle Scholar
  176. Urnovitz, H.B., M. Clerici, G.M. Shearer, T.D. Gottfried, D.J. Robinson, L.I. Lutwick, L. Montagnier & D.V. Landers, 1993. HIV-1 antibody serum negativity with urine positivity. Lancet 342: 1458–1459.PubMedGoogle Scholar
  177. Vamvakas, E. & H.S. Kaplan, 1993. Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion 33: 111–118.PubMedGoogle Scholar
  178. Vandenbroucke, J.P. & V.P.A.M. Pardoel, 1989. An autopsy on epidemiologic methods: the case of `poppers’ in the early epidemic of the acquired immunodeficiency syndrome (AIDS). Am. J. Epidem. 129: 455–457.Google Scholar
  179. Van Griensven, G.J., E.M. de Vroom, J. Goodsmit & R.A. Coutinho, 1989. Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. Br. Med. J. 298: 218–221.Google Scholar
  180. Vega, M.A., R. Guigo & T.F. Smith, 1990. Autoimmune response in AIDS. Nature 345: 26.PubMedGoogle Scholar
  181. Wang, M.C. & L.C. See, 1992. N-estimation from retrospectively ascertained events with application to AIDS. Biometrics 48: 129–141.PubMedGoogle Scholar
  182. Wang, R.Y., J.W. Shih, T. Grandinetti, P.F. Pierce, M.M. Hayes, D.J. Wear, H.J. Alter & S.C. Lo, 1992. High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients. Lancet 340: 1312–1316.PubMedGoogle Scholar
  183. Ward, J.W., T.J. Bush, H.A. Perkins, et al., 1989. The natural history of transfusion-associated infection with human immunodeficiency virus. New Engl. J. Med. 321: 947–952.PubMedGoogle Scholar
  184. Watson, H.G. & C.A. Ludlum, 1992. Immunological abnormalities in haemophiliacs. Blood Rev. 6: 26–33.PubMedGoogle Scholar
  185. Weber, R., W. Ledergerber, M. Opravil, W. Siegenthaler & R. Lüthy, 1990. Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. Br. Med. J. 301: 1361–1365.Google Scholar
  186. Webster, A., C.A. Lee, D.G. Cook, J.E. Grundy, et al., 1989. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet 11: 63–66.Google Scholar
  187. Weiss, R.A., 1993. How does HIV cause AIDS? Science 260: 1273–1279.PubMedGoogle Scholar
  188. Weyer, J. & H.J. Eggers, 1990. On the structure of the epidemic spread of AIDS: the influence of an infectious coagent. Int. J. Med. Microbiol. 273: 52–67.Google Scholar
  189. Winkelstein, W. Jr., J.A. Wiley, N.S. Padian, M. Samuel, S. Shiboski, M.S. Ascher & J.A. Levy, 1988. The San Francisco Men’s Health Study: Continued decline in HIV seroconversion rates among homosexual/bisexual men. Am. J. Public Health 78: 1472–1474.PubMedGoogle Scholar
  190. Witebsky, E., N.R. Rose, K. Terplan, J.R. Pain & R.W. Egan, 1957. Chronic thyroiditis and autoimmunization. JAMA 164: 1439–1447.Google Scholar
  191. Zarling, J.M., J.A. Ledbetter, J. Sias, P. Fultz, J. Eichberg, G. Gjerset & P.A. Moran, 1990. HIV-infected humans but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells. J. Immunol. 144, 2992–2998.PubMedGoogle Scholar
  192. Ziegler, J.L. & D.P. Stites, 1986. Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropicretrovirus. Clin. Immunol. Immunopathol. 41: 305.PubMedGoogle Scholar
  193. Zuck, T.F., 1988. Silent sequences and the safety of blood transfusions. Ann. Intern. Med. 108: 895–896.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Robert S. Root-Bernstein
    • 1
  1. 1.Department of PhysiologyMichigan State UniversityEast LansingUSA

Personalised recommendations